Description of the efficacy and safety of three new biologics in the treatment of rheumatoid arthritis.
about
Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targetsNon-infectious pulmonary complications of newer biological agents for rheumatic diseases--a systematic literature review.Choice of Biologic Therapy for Patients with Rheumatoid Arthritis: The Infection Perspective.Recent paradigm shifts in the diagnosis and treatment of rheumatoid arthritis.TNF-α inhibitors: are they carcinogenic?Unexpected hematologic effects of biotherapeutics in nonclinical species and in humans.Adverse effects of golimumab in the treatment of rheumatologic diseases.Anti-IL-17 therapy in treatment of rheumatoid arthritis: a systematic literature review and meta-analysis of randomized controlled trials.Severe infection in patients with rheumatoid arthritis taking anakinra, rituximab, or abatacept: a systematic review of observational studies.2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.Fostamatinib, an oral spleen tyrosine kinase inhibitor, in the treatment of rheumatoid arthritis: a meta-analysis of randomized controlled trials.European perspective on the management of rheumatoid arthritis: clinical utility of tofacitinib.Comparison of the disease activity score using the erythrocyte sedimentation rate and C-reactive protein levels in Koreans with rheumatoid arthritis.Contribution of subjective Disease Activity Score 28 (DAS28) components to the response to treatment of rheumatoid arthritis.2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee ArthroplastyAdditional effect of etanercept or infliximab on the liver function tests of patients with rheumatoid arthritis: a cohort study
P2860
Q26830569-CBA405F3-7C06-4D20-A322-4ACC0FC83002Q31039549-940F0D54-507F-4431-A965-E282BAEE479FQ35237588-1D6E8AD1-80B7-42B0-91C9-9BBC11D03359Q36485737-834D7155-40C9-420A-9656-46B3A3DFF91EQ37893973-1F8CFC1E-428B-43DC-A9C3-1660A3053B11Q38087506-8B18B59B-535E-40CA-9B8B-FC1B5906230BQ38132273-5B9A8268-A9D3-4841-8DDF-C72A980C8CB7Q38815234-A3145475-9AA2-4F97-AACE-627EC5F10A0BQ38983259-0E98380B-C075-436A-8BFC-5D58BC9BAF1BQ39377679-02F61390-A3D7-4A0E-AE1B-395339CCF056Q40699579-1F9ADB39-6880-4561-BE85-8FA89F410DB2Q47338654-56EDE586-36BA-413F-80F0-67072E76F723Q50534516-D8DA7FFD-7217-4B2B-9DE3-AD552785F6C5Q51030572-DA1AD17C-6C90-4FC8-9759-7B136A2DE412Q57245353-F8AC32E2-C8B2-48E0-9172-E6E95E24A9ADQ57817317-4CD50BC9-897E-46A3-82A3-3B8A558BE17B
P2860
Description of the efficacy and safety of three new biologics in the treatment of rheumatoid arthritis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 February 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Description of the efficacy an ...... tment of rheumatoid arthritis.
@en
Description of the efficacy an ...... tment of rheumatoid arthritis.
@nl
type
label
Description of the efficacy an ...... tment of rheumatoid arthritis.
@en
Description of the efficacy an ...... tment of rheumatoid arthritis.
@nl
prefLabel
Description of the efficacy an ...... tment of rheumatoid arthritis.
@en
Description of the efficacy an ...... tment of rheumatoid arthritis.
@nl
P2093
P2860
P921
P356
P1476
Description of the efficacy an ...... tment of rheumatoid arthritis.
@en
P2093
Daniel E Furst
Harsh Agrawal
Steven S Storage
P2860
P356
10.3904/KJIM.2010.25.1.1
P577
2010-02-26T00:00:00Z
2010-03-01T00:00:00Z